Abstract
This report examines international trade and worldwide market trends
pertaining to erythromycin and its derivatives. The report will be of
considerable interest primarily to relevant strategic planners, senior company
officials and importers/exporters, since it features invaluable information on
erythromycin and its derivatives export/import operations segmented by country
and region. The report covers the 2002-2006 period, with more emphasis on
foreign trade in 2006.
The report provides the following analytical materials on the erythromycin and
its derivatives: general description, international trade dynamics
(2002-2006), exports/imports (2006) broken down by country, major suppliers
and consumers, average price, international trade prospects, world market
development forecast for 2007-2011.
International trade operations in more than 125 countries are highlighted
through 150 tables and diagrams.